United They Stand? Differing Device Platforms Share FDA Oversight Plank
This article was originally published in The Gray Sheet
Executive Summary
Device advocacy groups credit a maturing industry presence on Capitol Hill, reflected by CEO-level participation, with achieving relevant Medicare reforms and a focus on FDA accountability
You may also be interested in...
AdvaMed President Ubl Brings Detailed Policy Approach To Industry Agenda
The choice of Stephen Ubl as AdvaMed's president & CEO reflects board members' preference for detailed knowledge of the industry over mere political clout
AdvaMed President Ubl Brings Detailed Policy Approach To Industry Agenda
The choice of Stephen Ubl as AdvaMed's president & CEO reflects board members' preference for detailed knowledge of the industry over mere political clout
Medicare Technical Corrections Legislation Doubtful After Rx Bill Passage
The resolve of House Republican leaders to avoid re-opening the controversial Medicare law with a technical corrections bill in 2004 will limit DME competitive bidding opponents' options in repealing the provision